595 related articles for article (PubMed ID: 25109239)
1. Long-term safety and efficacy of zonisamide versus carbamazepine monotherapy for treatment of partial seizures in adults with newly diagnosed epilepsy: results of a phase III, randomized, double-blind study.
Baulac M; Patten A; Giorgi L
Epilepsia; 2014 Oct; 55(10):1534-43. PubMed ID: 25109239
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and tolerability of zonisamide versus controlled-release carbamazepine for newly diagnosed partial epilepsy: a phase 3, randomised, double-blind, non-inferiority trial.
Baulac M; Brodie MJ; Patten A; Segieth J; Giorgi L
Lancet Neurol; 2012 Jul; 11(7):579-88. PubMed ID: 22683226
[TBL] [Abstract][Full Text] [Related]
3. A randomized phase III trial of adjunctive zonisamide in pediatric patients with partial epilepsy.
Guerrini R; Rosati A; Segieth J; Pellacani S; Bradshaw K; Giorgi L
Epilepsia; 2013 Aug; 54(8):1473-80. PubMed ID: 23837461
[TBL] [Abstract][Full Text] [Related]
4. Adjunctive zonisamide therapy in the long-term treatment of children with partial epilepsy: results of an open-label extension study of a phase III, randomized, double-blind, placebo-controlled trial.
Guerrini R; Rosati A; Bradshaw K; Giorgi L
Epilepsia; 2014 Apr; 55(4):568-78. PubMed ID: 24621319
[TBL] [Abstract][Full Text] [Related]
5. Safety and tolerability of zonisamide in elderly patients with epilepsy.
Trinka E; Giorgi L; Patten A; Segieth J
Acta Neurol Scand; 2013 Dec; 128(6):422-8. PubMed ID: 23773051
[TBL] [Abstract][Full Text] [Related]
6. Long-term efficacy and safety of eslicarbazepine acetate monotherapy for adults with newly diagnosed focal epilepsy: An open-label extension study.
Trinka E; Rocamora R; Chaves J; Moreira J; Ikedo F; Soares-da-Silva P;
Epilepsia; 2020 Oct; 61(10):2129-2141. PubMed ID: 32944934
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of eslicarbazepine acetate versus controlled-release carbamazepine monotherapy in newly diagnosed epilepsy: A phase III double-blind, randomized, parallel-group, multicenter study.
Trinka E; Ben-Menachem E; Kowacs PA; Elger C; Keller B; Löffler K; Rocha JF; Soares-da-Silva P
Epilepsia; 2018 Feb; 59(2):479-491. PubMed ID: 29369348
[TBL] [Abstract][Full Text] [Related]
8. Open-label, long-term safety study of zonisamide administered to children and adolescents with epilepsy.
Shinnar S; Pellock JM; Conry JA
Eur J Paediatr Neurol; 2009 Jan; 13(1):3-9. PubMed ID: 18343174
[TBL] [Abstract][Full Text] [Related]
9. Long-term safety and efficacy of lacosamide and controlled-release carbamazepine monotherapy in patients with newly diagnosed epilepsy.
Ben-Menachem E; Grebe HP; Terada K; Jensen L; Li T; De Backer M; Steiniger-Brach B; Gasalla T; Brock M; Biton V
Epilepsia; 2019 Dec; 60(12):2437-2447. PubMed ID: 31755090
[TBL] [Abstract][Full Text] [Related]
10. Safety and tolerability of zonisamide in paediatric patients with epilepsy.
Cross JH; Auvin S; Patten A; Giorgi L
Eur J Paediatr Neurol; 2014 Nov; 18(6):747-58. PubMed ID: 25128350
[TBL] [Abstract][Full Text] [Related]
11. Safety and tolerability of lacosamide as adjunctive therapy for adults with partial-onset seizures: Analysis of data pooled from three randomized, double-blind, placebo-controlled clinical trials.
Biton V; Gil-Nagel A; Isojarvi J; Doty P; Hebert D; Fountain NB
Epilepsy Behav; 2015 Nov; 52(Pt A):119-27. PubMed ID: 26414341
[TBL] [Abstract][Full Text] [Related]
12. Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: a phase III randomized, double-blind, placebo-controlled trial.
Biton V; Berkovic SF; Abou-Khalil B; Sperling MR; Johnson ME; Lu S
Epilepsia; 2014 Jan; 55(1):57-66. PubMed ID: 24446953
[TBL] [Abstract][Full Text] [Related]
13. Long-term safety and efficacy of zonisamide in patients with refractory partial-onset epilepsy.
Wroe SJ; Yeates AB; Marshall A
Acta Neurol Scand; 2008 Aug; 118(2):87-93. PubMed ID: 18547272
[TBL] [Abstract][Full Text] [Related]
14. Zonisamide: its pharmacology, efficacy and safety in clinical trials.
Brodie MJ; Ben-Menachem E; Chouette I; Giorgi L
Acta Neurol Scand Suppl; 2012; (194):19-28. PubMed ID: 23106522
[TBL] [Abstract][Full Text] [Related]
15. Adjunctive brivaracetam in adults with uncontrolled focal epilepsy: results from a double-blind, randomized, placebo-controlled trial.
Ryvlin P; Werhahn KJ; Blaszczyk B; Johnson ME; Lu S
Epilepsia; 2014 Jan; 55(1):47-56. PubMed ID: 24256083
[TBL] [Abstract][Full Text] [Related]
16. Dose-dependent safety and efficacy of zonisamide: a randomized, double-blind, placebo-controlled study in patients with refractory partial seizures.
Brodie MJ; Duncan R; Vespignani H; Solyom A; Bitenskyy V; Lucas C
Epilepsia; 2005 Jan; 46(1):31-41. PubMed ID: 15660766
[TBL] [Abstract][Full Text] [Related]
17. Zonisamide: a review of its use in the management of adults with partial seizures.
Hoy SM
Drugs; 2013 Aug; 73(12):1321-38. PubMed ID: 23873520
[TBL] [Abstract][Full Text] [Related]
18. Efficacy, safety, and tolerability of lacosamide monotherapy versus controlled-release carbamazepine in patients with newly diagnosed epilepsy: a phase 3, randomised, double-blind, non-inferiority trial.
Baulac M; Rosenow F; Toledo M; Terada K; Li T; De Backer M; Werhahn KJ; Brock M
Lancet Neurol; 2017 Jan; 16(1):43-54. PubMed ID: 27889312
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the cognitive effects of tiagabine and carbamazepine as monotherapy in newly diagnosed adult patients with partial epilepsy: pooled analysis of two long-term, randomized, follow-up studies.
Aikiä M; Jutila L; Salmenperä T; Mervaala E; Kälviäinen R
Epilepsia; 2006 Jul; 47(7):1121-7. PubMed ID: 16886974
[TBL] [Abstract][Full Text] [Related]
20. Zonisamide: new drug. No advantage in refractory partial epilepsy.
Prescrire Int; 2007 Jun; 16(89):95-7. PubMed ID: 17582922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
